130 related articles for article (PubMed ID: 38396337)
1. The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trials.
Genge A; Cedarbaum JM; Shefner J; Chio A; Al-Chalabi A; Van Damme P; McDermott C; Glass J; Berry J; van Eijk RPA; Fournier C; Grosskreutz J; Andrews J; Bertone V; Bunte TM; Couillard M; Cummings C; Kittle G; Polzer J; Salmon K; Straub C; van den Berg LH
Amyotroph Lateral Scler Frontotemporal Degener; 2024 May; 25(3-4):382-387. PubMed ID: 38396337
[TBL] [Abstract][Full Text] [Related]
2. Categorization of the amyotrophic lateral sclerosis population via the clinical determinant of post-onset ΔFS for study design and medical practice.
Ludolph AC; Corcia P; Desnuelle C; Heiman-Patterson T; Mora JS; Mansfield CD; Couratier P
Muscle Nerve; 2024 Jul; 70(1):36-41. PubMed ID: 38712849
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal comparison of the self-entry Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-RSE) and Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) as outcome measures in people with amyotrophic lateral sclerosis.
Johnson SA; Burke KM; Scheier ZA; Keegan MA; Clark AP; Chan J; Fournier CN; Berry JD
Muscle Nerve; 2022 Oct; 66(4):495-502. PubMed ID: 35904151
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS).
Fournier CN; Bedlack R; Quinn C; Russell J; Beckwith D; Kaminski KH; Tyor W; Hertzberg V; James V; Polak M; Glass JD
JAMA Neurol; 2020 Apr; 77(4):480-488. PubMed ID: 31886839
[TBL] [Abstract][Full Text] [Related]
5. Improving the measurement properties of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): deriving a valid measurement total for the calculation of change.
Young CA; Chaouch A; Mcdermott CJ; Al-Chalabi A; Chhetri SK; Talbot K; Malaspina A; Mills R; Tennant A
Amyotroph Lateral Scler Frontotemporal Degener; 2024 May; 25(3-4):400-409. PubMed ID: 38426231
[TBL] [Abstract][Full Text] [Related]
6. Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self-report scale (Center for Neurologic Study Bulbar Function Scale).
Smith RA; Macklin EA; Myers KJ; Pattee GL; Goslin KL; Meekins GD; Green JR; Shefner JM; Pioro EP
Eur J Neurol; 2018 Jul; 25(7):907-e66. PubMed ID: 29577526
[TBL] [Abstract][Full Text] [Related]
7. Remote-Use Applications of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised Clinical Outcome Assessment Tool: A Scoping Review.
Bhushan NL; Romano CD; Gras-Najjar J; Reno J; Rockwood N; Quattrone W; Adams ET; Kelly B; McLeod L; Bhavnani SP; Bocell FD; Campbell M; Kontson K; Reasner D; Zhang C; Retzky S
Value Health; 2024 May; ():. PubMed ID: 38795957
[TBL] [Abstract][Full Text] [Related]
8. Patient reported outcomes in ALS: characteristics of the self-entry ALS Functional Rating Scale-revised and the Activities-specific Balance Confidence Scale.
Chew S; Burke KM; Collins E; Church R; Paganoni S; Nicholson K; Babu S; Scalia JB; De Marchi F; Ellrodt AL; Moura LMVR; Chan J; Berry JD
Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):467-477. PubMed ID: 33771057
[No Abstract] [Full Text] [Related]
9. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
;
Lancet Neurol; 2017 Jul; 16(7):505-512. PubMed ID: 28522181
[TBL] [Abstract][Full Text] [Related]
10. Six-Minute Walk Test as a Measure of Walking Capacity in Ambulatory Individuals With Amyotrophic Lateral Sclerosis.
Sanjak M; Langford V; Holsten S; Rozario N; Patterson CGM; Bravver E; Bockenek WL; Brooks BR
Arch Phys Med Rehabil; 2017 Nov; 98(11):2301-2307. PubMed ID: 28465220
[TBL] [Abstract][Full Text] [Related]
11. A retrospective investigation of the relationship between baseline covariates and rate of ALSFRS-R decline in ALS clinical trials.
Daghlas I; Lever TE; Leary E
Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):206-211. PubMed ID: 29260911
[TBL] [Abstract][Full Text] [Related]
12. ALSFRS-R-SE: an adapted, annotated, and self-explanatory version of the revised amyotrophic lateral sclerosis functional rating scale.
Maier A; Boentert M; Reilich P; Witzel S; Petri S; Großkreutz J; Metelmann M; Lingor P; Cordts I; Dorst J; Zeller D; Günther R; Hagenacker T; Grehl T; Spittel S; Schuster J; Ludolph A; Meyer T;
Neurol Res Pract; 2022 Dec; 4(1):60. PubMed ID: 36522775
[TBL] [Abstract][Full Text] [Related]
13. Qualitative measures that assess functional disability and quality of life in ALS.
Hartmaier SL; Rhodes T; Cook SF; Schlusser C; Chen C; Han S; Zach N; Murthy V; Davé S
Health Qual Life Outcomes; 2022 Jan; 20(1):12. PubMed ID: 35062955
[TBL] [Abstract][Full Text] [Related]
14. Ropinirole hydrochloride remedy for amyotrophic lateral sclerosis - Protocol for a randomized, double-blind, placebo-controlled, single-center, and open-label continuation phase I/IIa clinical trial (ROPALS trial).
Morimoto S; Takahashi S; Fukushima K; Saya H; Suzuki N; Aoki M; Okano H; Nakahara J
Regen Ther; 2019 Dec; 11():143-166. PubMed ID: 31384636
[TBL] [Abstract][Full Text] [Related]
15. [Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version].
Ohashi Y; Tashiro K; Itoyama Y; Nakano I; Sobue G; Nakamura S; Sumino S; Yanagisawa N
No To Shinkei; 2001 Apr; 53(4):346-55. PubMed ID: 11360474
[TBL] [Abstract][Full Text] [Related]
16. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
[TBL] [Abstract][Full Text] [Related]
17. Remote digital assessment of amyotrophic lateral sclerosis functional rating scale - a multicenter observational study.
Meyer T; Spittel S; Grehl T; Weyen U; Steinbach R; Kettemann D; Petri S; Weydt P; Günther R; Baum P; Schlapakow E; Koch JC; Boentert M; Wolf J; Grosskreutz J; Rödiger A; Ilse B; Metelmann M; Norden J; Koc RY; Körtvélyessy P; Riitano A; Walter B; Hildebrandt B; Schaudinn F; Münch C; Maier A
Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):175-184. PubMed ID: 35912984
[TBL] [Abstract][Full Text] [Related]
18. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).
Cedarbaum JM; Stambler N; Malta E; Fuller C; Hilt D; Thurmond B; Nakanishi A
J Neurol Sci; 1999 Oct; 169(1-2):13-21. PubMed ID: 10540002
[TBL] [Abstract][Full Text] [Related]
19. Assessing the Measurement Properties of the Self-Administered Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): A Rasch Analysis.
Mehdipour A; Teshler L; Dal Bello-Haas V; Richardson J; Beauchamp M; Turnbull J; Chum M; Johnston W; O'Connell C; Luth W; Kuspinar A
Phys Ther; 2023 Nov; 103(11):. PubMed ID: 37581600
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of ALSFRS-R Scale with Fuzzy Method in Amyotrophic Lateral Sclerosis.
Gül Koç G; Dağsuyu C; Kokangül A; Koç F
Noro Psikiyatr Ars; 2022; 59(1):54-62. PubMed ID: 35317505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
